Search results for: 'pace pharmaceutical'

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...

05 Feb 2021  |  North America  |  Market Research

Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market

Early-stage R&D and Commercial Applications Fuel the Growth Pipeline

Infographics

×

The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...

TechVision's latest research service from the medical device technology cluster highlights the game changing innovations in cardiovascular care. Although cardiovascular devices have been in use for decades, over the last few years, there have been some major developments in cardiovascular care. The technology innoavtions are powered by rapid advanc...

09 May 2019  |  North America  |  Market Outlook

Global Autonomous Driving (AD) Industry Outlook, 2019

1 in 4 Cars Sold (18 Million) Globally is Expected to be Automated (L3 and Above) by 2030, with L4 Driving the Growth of Ownership

Infographics

×

Key Issues Addressed

The autonomous driving industry is evolving at a rapid pace on various fronts such as advancements in technology as well as emergence of new business models. Traditionally, most major OEMs and Tier I suppliers have strived to explore the benefits of developing applications focused on the convergence of the three technology pillars: Connected, Auton...

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

21 May 2019  |  North America  |  Market Outlook

Global UCC Industry Outlook, 2019

Rich Media Capabilities Shine in the Next-gen Workplace

Infographics

×

The global UCC market continues to evolve at a rapid pace. Migration to cloud-based subscription services is accelerating as organizations gain confidence, existing CPE assets near end of life, and current cloud services deployments expand to more sites, users and applications. The gap between “as a service” offerings and other consumption model...

The North American hosted IP telephony and UCaaS market continues to expand at a steady pace, creating significant growth opportunities for providers with differentiated solution offerings, robust platforms and architectures, and effective go-to-market strategies tailored for specific customer segments. Both demand and supply factors are driving ma...

28 Jun 2021  |  North America  |  Market Outlook

Global Medical Imaging & Informatics Outlook, 2021

AI, Long-term Partnerships, and Cloud to Influence Growth Strategies

Infographics

×

The global medical imaging and informatics market is experiencing dynamic changes with the emergence of advanced technologies, evolving clinical and administrative needs, and the introduction of new policies and regulations, which is forcing industry participants to innovate to maintain their competitive edge. Technologies such as artificial intell...